Note that some links may require registration or subscription.
Skepticism and rage may be a theme uniting President-elect Donald Trump's top picks to lead the nation's healthcare system, an article in the Atlantic suggested.
Trump is , an associate of billionaire investor and early Trump backer Peter Thiel, for the position of HHS deputy secretary. (Politico)
Meanwhile, Trump's plans to reinstate travel bans have . (STAT)
Liberal die-hards and conservative moms are in the Make America Health Again (MAHA)-verse. (STAT)
Thousands of resident physicians across five major hospital systems in Philadelphia rallied, . (WHYY)
Amgen announced positive data from its phase II study of investigational maridebart cafraglutide (MariTide), with findings suggesting at 52 weeks.
In 2023, 140 at the hands of their partner or a close relative, a United Nations report showed.
In response to a New York City stabbing spree last week that left three people dead, Mayor Eric Adams renewed his that would clarify and expand criteria for individuals to be hospitalized for psychiatric care against their will. (Gothamist)
Texas public health officials announced the of dengue this year.
The U.S. Supreme Court a challenge to a federal requirement that cigarette packaging and advertising include graphic images depicting the effects of smoking. (AP)
Thousands of people have been each month as the FDA weighs the drug's shortage status. (Reuters)
West Virginia for GLP-1 drugs. (CBS News)
A pair of rival hospitals in Indiana , shortly before the state was expected to rule on the deal amid growing backlash against medical monopolies. (KFF Health News)
This is patients at their homes. (Washington Post)
The Canadian Food Inspection Agency determined that a lab error of Church Brothers Farms' Green Onions; the recall was rescinded.
A shocking discovery and difficult decisions followed an . (New York Times)
The phase III ZENITH study of sotatercept-csrk (Winrevair) in adults with pulmonary arterial hypertension functional class III or IV at high risk of mortality , drugmaker Merck reported.
Cassava Sciences said a phase III of investigational simufilam for Alzheimer's disease and pulled the plug on a second phase III study of the drug.
Long COVID patients and researchers want to see federal research . (NPR)
A Missouri judge banning some gender-affirming care for minors. (ABC News)
Amid stringent abortion laws, Texas ob/gyns have been . (New Yorker)
High-intensity drinking, which is on the rise in middle-aged drinkers, is . (New York Times)